ロード中...
Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
The therapeutic success of BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) in BRAF-mutant melanoma is limited by the emergence of drug resistance, and several lines of evidence suggest that changes in the tumor microenvironment can play a pivotal role in acquired resistance. The present study focu...
保存先:
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7830125/ https://ncbi.nlm.nih.gov/pubmed/33467521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9010079 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|